Stock listing

TPEx:6580 TaiRx, Inc. (台睿) 股價

Follow TaiRx, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6580

$10.90 TWD -0.40 (-3.5%)

Close on Nov 20, 2026

Past year -51.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$10.50 – $11.40 TWDNov 20, 2026
Volume
99,326 sharesNov 20, 2026
Market cap
$1.22B TWDAt the close on Nov 20, 2026 · price × 112.1M shares outstanding
52-week range
$9.99 – $23.60 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.33M TWDMedian day 72,515 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
TaiRx, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6580 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.90-0.40-3.5%$11.40$11.40$10.5099,326
$11.30+0.30+2.7%$11.00$11.45$10.9044,035
$11.00-1.05-8.7%$12.05$12.05$10.8094,721
$12.05+1.50+14.2%$10.55$12.20$10.30220,635
$10.55+0.05+0.5%$10.50$10.60$10.2560,713
$10.50-0.40-3.7%$10.90$10.90$10.3047,733
$10.90-0.25-2.2%$11.15$11.15$10.45154,248
$11.15+0.05+0.5%$11.10$11.40$11.0096,826
$11.100.000.0%$11.10$11.25$10.9037,582
$11.10-0.35-3.1%$11.10$11.25$9.99183,222
$11.45+0.05+0.4%$11.35$11.55$11.1054,063
$11.40-0.35-3.0%$11.75$11.75$11.3085,503
$11.75-0.50-4.1%$12.25$12.40$11.45219,963
$12.25+0.30+2.5%$12.00$12.25$11.90105,356
$11.95-0.60-4.8%$12.55$12.55$11.9086,499
$12.550.000.0%$12.15$12.55$12.1044,260
$12.55-0.30-2.3%$12.85$12.85$11.85166,081
$12.85-0.15-1.2%$12.80$12.90$12.5018,032
$13.00+0.20+1.6%$13.00$13.00$13.000
$12.80-0.40-3.0%$13.25$13.25$12.5058,960
$13.20-0.50-3.6%$13.20$13.45$12.75109,535
$13.70+0.70+5.4%$13.15$13.70$13.0057,820
$13.00-0.55-4.1%$13.25$13.25$13.0072,754
$13.55+0.20+1.5%$13.50$13.75$13.3050,753
$13.35-0.65-4.6%$14.05$14.05$13.0094,069
$14.00-0.30-2.1%$14.25$14.25$13.70122,384
$14.30-0.20-1.4%$14.50$14.55$14.0026,443
$14.50-0.05-0.3%$14.25$14.50$14.0526,026
$14.55+0.15+1.0%$14.30$14.65$14.0069,075
$14.40-0.65-4.3%$14.65$15.05$14.35151,236
$15.05-0.40-2.6%$15.40$15.40$14.6586,956
$15.45+0.05+0.3%$15.60$15.60$15.0053,599
$15.40-0.35-2.2%$15.20$15.80$15.00114,728
$15.75+0.30+1.9%$15.90$16.30$15.4089,906
$15.45+1.10+7.7%$14.35$16.00$14.15236,829
$14.35-0.10-0.7%$14.50$14.50$13.95105,429
$14.45-0.05-0.3%$14.50$14.50$14.0034,747
$14.500.000.0%$14.55$14.60$13.9521,449
$14.50-0.70-4.6%$14.60$15.05$14.1596,701
$15.20-0.35-2.3%$15.70$15.70$14.65179,456
$15.55+1.35+9.5%$14.30$16.35$14.00392,967
$14.20+0.20+1.4%$13.80$14.25$13.8072,275
$14.00-0.70-4.8%$14.95$14.95$13.90106,521
$14.70-0.65-4.2%$16.25$16.25$14.35308,438
$15.35+2.30+17.6%$13.10$16.15$13.05647,038
$13.05+0.10+0.8%$12.60$13.10$12.60141,514
$12.95+0.50+4.0%$12.45$12.95$12.45114,054
$12.450.000.0%$12.50$12.70$12.3058,807
$12.45+0.05+0.4%$12.60$12.70$12.4516,208
$12.40-0.15-1.2%$12.70$12.70$12.3550,407
$12.55+0.05+0.4%$12.75$12.75$12.3550,005
$12.50-0.20-1.6%$12.80$12.80$12.3589,043
$12.70-0.20-1.6%$12.60$12.75$12.5020,054
$12.90+0.10+0.8%$12.90$12.90$12.604,017
$12.80-0.25-1.9%$13.05$13.05$12.6022,254
$13.05+0.50+4.0%$12.70$13.05$12.6539,505
$12.55+0.25+2.0%$12.60$12.60$12.2547,012
$12.30-0.20-1.6%$12.50$12.50$12.2053,554
$12.50+0.15+1.2%$12.30$12.55$12.2533,035
$12.35-0.20-1.6%$12.55$12.55$12.3525,324
$12.55-0.30-2.3%$12.50$12.55$12.30131,530
$12.85-0.05-0.4%$12.70$13.00$12.6513,258

Splits

1 split · TPEX:6580 · every price before a split is adjusted for it

DayRatioWhat
17-for-20Consolidation
Ticker
TPEx:6580
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

TaiRx, Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 33.8× against a median of 11.6×: 5th lowest of 7 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$943.2M TWD
P/E
Loss
EV/sales
33.8×
EV/EBITDA
Negative EBITDA
Price/book
3.3×
Gross margin
36.2%
Operating margin
−851.5%
Net margin
−793.3%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
TaiRx, Inc. · TPEX:6580US$37.07MUS$28.61Mn/a33.8×n/a3.3×−793.3%0.0×n/a
Quratis Inc. · KRX:348080US$38.37MUS$29.48Mn/a36.2×n/a1.1×n/a0.0×n/a
OSE Immunotherapeutics SA · EURONEXT:OSEUS$38.31MUS$52.28Mn/a18.2×n/a1.3×n/a1.3×n/a
KoBioLabs, Inc. · KRX:348150US$38.23MUS$6.96Mn/a0.1×n/a1.8×−6.4%0.2×n/a
Sprint Bioscience AB · OMXSTO:SPRINTUS$38.02MUS$28.89M5.1×2.1×3.7×4.3×54.4%0.0×n/a
Theralase Technologies Inc. · TSXV:TLTUS$37.89MUS$34.22Mn/a61.1×n/a7.9×−472.5%0.0×0.75
Connect Biopharma Holdings Limited · NASDAQ:CNTBUS$37.15MUS$18.16Mn/a4.9×n/a3.1×n/a0.0×0.93
Coiled Therapeutics PLC · LSE:COILUS$37.13MUS$30.46Mn/an/an/a0.6×n/a0.0×n/a
Pliant Therapeutics, Inc. · NASDAQ:PLRXUS$36.89M−US$104.2Mn/an/an/a0.3×n/a0.0×1.06
Arovella Therapeutics Limited · ASX:ALAUS$36.01MUS$26.51Mn/an/an/a3.8×n/a0.0×n/a
Grace Therapeutics, Inc. · NASDAQ:GRCEUS$35.97MUS$14.66Mn/an/an/a0.7×n/a0.0×0.77
Median of the othersUS$37.52MUS$27.70M5.1×11.6×3.7×1.5×−6.4%0.0×0.85

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue27.9M8.22M5.08M6.92M5.14M3.36M3.16M
Cost of revenue17.8M6.88M2.64M2.97M2.69M1.76M1.65M
Gross profit10.1M1.34M2.44M3.95M2.45M1.60M1.50M
Research and development175.5M102.8M173.1M168.5M84.5M118.7M178.8M
Selling, general and administrative71.9M43.9M43.6M48.4M48.0M45.8M45.8M
Operating income-237.4M-146.0M-214.7M-213.1M-130.2M-163.0M-163.2M
Depreciation and amortization7.94M7.32M3.31M4.22M4.34M4.34M4.33M
EBITDA-229.4M-138.6M-211.4M-208.9M-125.8M-158.7M-158.9M
Interest expense167.0K275.0K332.0K172.0K146.0K190.0K619.0K
Income before tax-222.4M-138.8M-212.3M-211.6M-127.5M-162.3M-220.8M
Income tax-3.06M
Net income-221.1M-138.8M-212.3M-211.6M-125.6M-159.4M-217.8M
Earnings per share, basic-1.97-1.26-2.31-2.37-1.38-2.37-3.60

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents136.2M114.0M160.2M34.9M34.0M91.4M51.3M
Short-term investments200.0M400.0M500.0M323.4M510.7M582.7M274.6M
Receivables10.3M275.0K27.8M1.81M3.58M23.4M19.9M
Inventory3.15M171.0K11.0K18.0K0
Current assets392.0M547.1M689.3M386.4M571.4M698.6M346.7M
Total assets465.2M684.8M833.7M534.0M706.6M837.3M489.3M
Accounts payable2.51M00994.0K1.97M1.94M921.0K
Current liabilities21.1M25.1M46.1M36.8M24.8M30.4M26.2M
Total debt10.4M12.3M15.5M2.42M5.60M8.76M
Total liabilities23.6M36.3M60.6M54.9M30.8M39.4M31.8M
Shareholders' equity441.6M647.2M771.8M477.8M674.6M788.7M451.3M
Shares outstanding112.1M110.1M91.9M89.4M90.9M67.3M60.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-178.5M-149.8M-194.9M-185.7M-124.4M-142.0M-168.9M
Capital spending-1.15M-321.0K-313.0K-317.0K-946.0K-401.0K0
Free cash flow-179.6M-150.1M-195.2M-186.0M-125.4M-142.4M-168.9M
Cash from investing99.7M-176.7M187.0M71.1M-308.7M100.4M
Cash from financing3.87M496.9M-409.0K-3.71M490.8M-33.7M
Share buybacks-108.8M
Change in cash22.3M-46.2M125.3M902.0K-57.4M40.1M-102.3M

Open Financials

Cap table

Built by 6ix from TaiRx, Inc.’s releases

Common shares
112,120,000
Fully diluted
112,120,000

Fully diluted

LineShares
Common shares112,120,000

Share count over time

CountShares
Nov 22, 2026112,120,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
醫睿醫藥科技股份有限公司8.78M7.8%Oct 31, 2026
朱伊文864K0.77%Oct 31, 2026
林632K0.56%Oct 31, 2026
簡督憲614K0.55%Oct 31, 2026
黃仕旗236K0.21%Oct 31, 2026
郭盛助114K0.10%Oct 31, 2026
吳天賞85,6320.08%Oct 31, 2026
陳彥鴒23,0000.02%Oct 31, 2026
周怡利5,000<0.01%Oct 31, 2026
諸仲強00.00%Oct 31, 2026
All 14 holders
HolderSharesOf the companyAs of
徐文祺00.00%Oct 31, 2026
張振武00.00%Oct 31, 2026
林玉寬00.00%Oct 31, 2026
洪瑀彤00.00%Oct 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about TaiRx, Inc.